Your browser doesn't support javascript.
loading
Immunogenicity of COVID-19 vaccines and levels of SARS-CoV-2 neutralising antibody in the Bruneian population: Protocol for a national longitudinal study.
Ghani, Hazim; Ahmad, Liyana; Sharif, Hanisah; Wong, Justin; Bagol, Saifuddien; Alikhan, Mohammad Fathi; Taib, Surita; Tan, Chee Wah; Zhu, Feng; Ong, Xin Mei; Shim, Chin Yee; Wang, Yan; Chan, Si Yee; Wei, Yuan; Idris, Fazean; Naing, Lin; Wang, Lin-Fa; Cunningham, Anne Catherine.
Affiliation
  • Ghani H; PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, Brunei Darussalam hazim.ghani@ubd.edu.bn.
  • Ahmad L; PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, Brunei Darussalam.
  • Sharif H; PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, Brunei Darussalam.
  • Wong J; PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, Brunei Darussalam.
  • Bagol S; Disease Control Division, Ministry of Health Brunei Darussalam, Bandar Seri Begawan, Brunei-Muara, Brunei Darussalam.
  • Alikhan MF; Department of Laboratory Services, Ministry of Health Brunei Darussalam, Bandar Seri Begawan, Brunei-Muara, Brunei Darussalam.
  • Taib S; EVYD Research Pte Ltd, A Subsidiary of EVYD Technology Limited, Singapore.
  • Tan CW; Department of Laboratory Services, Ministry of Health Brunei Darussalam, Bandar Seri Begawan, Brunei-Muara, Brunei Darussalam.
  • Zhu F; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Ong XM; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Shim CY; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Wang Y; EVYD Research Pte Ltd, A Subsidiary of EVYD Technology Limited, Singapore.
  • Chan SY; EVYD Research Pte Ltd, A Subsidiary of EVYD Technology Limited, Singapore.
  • Wei Y; EVYD Research Pte Ltd, A Subsidiary of EVYD Technology Limited, Singapore.
  • Idris F; EVYD Research Pte Ltd, A Subsidiary of EVYD Technology Limited, Singapore.
  • Naing L; PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, Brunei Darussalam.
  • Wang LF; PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, Brunei Darussalam.
  • Cunningham AC; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
BMJ Open ; 12(12): e067020, 2022 12 01.
Article de En | MEDLINE | ID: mdl-36456015
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins contre la COVID-19 / COVID-19 Type d'étude: Observational_studies / Risk_factors_studies Aspects: Ethics Limites: Adult / Humans Pays/Région comme sujet: Asia Langue: En Journal: BMJ Open Année: 2022 Type de document: Article Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins contre la COVID-19 / COVID-19 Type d'étude: Observational_studies / Risk_factors_studies Aspects: Ethics Limites: Adult / Humans Pays/Région comme sujet: Asia Langue: En Journal: BMJ Open Année: 2022 Type de document: Article Pays de publication: Royaume-Uni